abecma
Generic: idecabtagene vicleucel
Labeler: celgene corporationDrug Facts
Product Profile
Brand Name
abecma
Generic Name
idecabtagene vicleucel
Labeler
celgene corporation
Dosage Form
SUSPENSION
Routes
Active Ingredients
idecabtagene vicleucel 300000000 1/1
Manufacturer
Identifiers & Regulatory
Product NDC
59572-515
Product ID
59572-515_49b988a5-ae62-4d6e-89c0-57e6f40459bc
Product Type
CELLULAR THERAPY
Marketing Category
BLA
Application Number
BLA125736
Listing Expiration
2026-12-31
Marketing Start
2021-03-26
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
59572515
Hyphenated Format
59572-515
Supplemental Identifiers
RxCUI
UNII
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
abecma (source: ndc)
Generic Name
idecabtagene vicleucel (source: ndc)
Application Number
BLA125736 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 300000000 1/1
Packaging
- 1 SUSPENSION in 1 BAG (59572-515-01)
- 1 SUSPENSION in 1 BAG (59572-515-02)
- 1 SUSPENSION in 1 BAG (59572-515-03)
Packages (3)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["INTRAVENOUS"], "spl_id": "49b988a5-ae62-4d6e-89c0-57e6f40459bc", "openfda": {"unii": ["8PX1X7UG4D"], "rxcui": ["2536434", "2536439", "2536443", "2536445", "2536449", "2536451"], "spl_set_id": ["b90c1fe7-f5cc-464e-958a-af36e9c26d7c"], "manufacturer_name": ["Celgene Corporation"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 SUSPENSION in 1 BAG (59572-515-01)", "package_ndc": "59572-515-01", "marketing_start_date": "20210326"}, {"sample": false, "description": "1 SUSPENSION in 1 BAG (59572-515-02)", "package_ndc": "59572-515-02", "marketing_start_date": "20210326"}, {"sample": false, "description": "1 SUSPENSION in 1 BAG (59572-515-03)", "package_ndc": "59572-515-03", "marketing_start_date": "20210326"}], "brand_name": "Abecma", "product_id": "59572-515_49b988a5-ae62-4d6e-89c0-57e6f40459bc", "dosage_form": "SUSPENSION", "product_ndc": "59572-515", "generic_name": "idecabtagene vicleucel", "labeler_name": "Celgene Corporation", "product_type": "CELLULAR THERAPY", "brand_name_base": "Abecma", "active_ingredients": [{"name": "IDECABTAGENE VICLEUCEL", "strength": "300000000 1/1"}], "application_number": "BLA125736", "marketing_category": "BLA", "marketing_start_date": "20210326", "listing_expiration_date": "20261231"}